{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:06:23Z","timestamp":1773464783827,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006244","name":"KIKA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["UVA2008-4265"],"award-info":[{"award-number":["UVA2008-4265"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ejca.2014.03.011","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T20:31:21Z","timestamp":1396557081000},"page":"1665-1674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101"],"prefix":"10.1016","volume":"50","author":[{"given":"Jill A.P.","family":"Spijkers-Hagelstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Mimoso","family":"Pinhan\u00e7os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Garrido Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald W.","family":"Stam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9583","key":"10.1016\/j.ejca.2014.03.011_b0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2014.03.011_b0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-4615-4811-9_35","article-title":"BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance","volume":"457","author":"Haarman","year":"1999","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.ejca.2014.03.011_b0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2000.01990.x","article-title":"Role of BCL-2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia","volume":"109","author":"Baghdassarian","year":"2000","journal-title":"Br J Haematol"},{"issue":"53","key":"10.1016\/j.ejca.2014.03.011_b0020","doi-asserted-by":"crossref","first-page":"55809","DOI":"10.1074\/jbc.M411767200","article-title":"Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA","volume":"279","author":"Abrams","year":"2004","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ejca.2014.03.011_b0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1163\/15685590152763737","article-title":"Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin\u2019s lymphoma in children","volume":"31","author":"Pituch-Noworolska","year":"2001","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.ejca.2014.03.011_b0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","article-title":"Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance","volume":"10","author":"Wei","year":"2006","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ejca.2014.03.011_b0035","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI39987","article-title":"Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance","volume":"120","author":"Bonapace","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ejca.2014.03.011_b0040","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1038\/cddis.2010.53","article-title":"GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy","volume":"16","author":"Heidari","year":"2010","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.ejca.2014.03.011_b0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.exphem.2010.11.009","article-title":"BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia","volume":"39","author":"Jiang","year":"2011","journal-title":"Exp Hematol"},{"issue":"4","key":"10.1016\/j.ejca.2014.03.011_b0050","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s12032-010-9641-x","article-title":"Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells","volume":"28","author":"Zhao","year":"2011","journal-title":"Med Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2014.03.011_b0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.leu.2405039","article-title":"The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia","volume":"22","author":"Ploner","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ejca.2014.03.011_b0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejca.2014.03.011_b0065","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1182\/blood-2009-02-205963","article-title":"Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia","volume":"115","author":"Stam","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejca.2014.03.011_b0070","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2007-12-126946","article-title":"Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells","volume":"112","author":"Balakrishnan","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejca.2014.03.011_b0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood-2008-02-138560","article-title":"AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated MCL1 induction and drug resistance","volume":"113","author":"Balakrishnan","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejca.2014.03.011_b0080","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/leu.2012.88","article-title":"Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia","volume":"26","author":"Billard","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.ejca.2014.03.011_b0085","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1124\/mol.106.024505","article-title":"The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism","volume":"70","author":"Gao","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"5\u20136","key":"10.1016\/j.ejca.2014.03.011_b0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.phrs.2008.09.005","article-title":"\u2013(\u2212)Gossypol promotes the apoptosis of bladder cancer cells in vitro","volume":"58","author":"Macoska","year":"2008","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.ejca.2014.03.011_b0095","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2141.2008.07100.x","article-title":"Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation","volume":"141","author":"Robinson","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2014.03.011_b0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.leu.2403231","article-title":"Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation","volume":"3","author":"Menendez","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2014.03.011_b0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2141.2011.08984.x","article-title":"Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner","volume":"157","author":"Masood","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ejca.2014.03.011_b0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/cbt.7.1.5128","article-title":"Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin\u2019s lymphoma cells","volume":"7","author":"Li","year":"2008","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"10.1016\/j.ejca.2014.03.011_b0115","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/1535-7163.MCT-08-0333","article-title":"Natural BH3 mimetic (\u2212)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa","volume":"7","author":"Meng","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.ejca.2014.03.011_b0120","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","article-title":"Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy","volume":"15","author":"Kang","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1\u20133","key":"10.1016\/j.ejca.2014.03.011_b0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2010.06.070","article-title":"Gossypol inhibits phosphorylation of Bcl-2 in human leukemia HL-60 cells","volume":"645","author":"Huang","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ejca.2014.03.011_b0130","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/MCB.00620-06","article-title":"Degradation of MCL1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization","volume":"11","author":"Ding","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.ejca.2014.03.011_b0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL1","volume":"1","author":"Maurer","year":"2006","journal-title":"Mol Cell"},{"issue":"14","key":"10.1016\/j.ejca.2014.03.011_b0140","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.febslet.2010.05.061","article-title":"MCL1; the molecular regulation of protein function","volume":"584","author":"Thomas","year":"2010","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.ejca.2014.03.011_b0145","first-page":"372","article-title":"Infant leukaemia biology, aetiology and treatment","volume":"10","author":"Greaves","year":"1996","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ejca.2014.03.011_b0150","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V92.1.259.413k21_259_266","article-title":"Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs","volume":"92","author":"Kaspers","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejca.2014.03.011_b0155","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"D\u00f6rdelmann","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2014.03.011_b0160","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2003.11.031","article-title":"Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia","volume":"17","author":"Den Boer","year":"2003","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.ejca.2014.03.011_b0165","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejca.2014.03.011_b0170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2402090","article-title":"Phosphorylation of Bcl2 and regulation of apoptosis","volume":"15","author":"Ruvolo","year":"2001","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.ejca.2014.03.011_b0175","first-page":"1707","article-title":"Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C","volume":"54","author":"Jarvis","year":"1994","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ejca.2014.03.011_b0180","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.leu.2404248","article-title":"Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AML","volume":"20","author":"Kurinna","year":"2006","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.ejca.2014.03.011_b0185","doi-asserted-by":"crossref","first-page":"23861","DOI":"10.1074\/jbc.M301843200","article-title":"Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.ejca.2014.03.011_b0190","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1182\/blood-2005-04-1595","article-title":"BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo","volume":"106","author":"Erlacher","year":"2005","journal-title":"Blood"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914002548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914002548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T05:59:17Z","timestamp":1597643957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804914002548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0959804914002548"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2014.03.011","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2014.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}